Since 1992, Omnicell has been creating innovative solutions to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software for medication and supply management across the entire health care continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient’s home. Approximately 4,000 customers worldwide use Omnicell automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety. The recent acquisition of Aesynt adds distinct capabilities, particularly in central pharmacy and IV robotics, creating the broadest medication management product portfolio in the industry. The Omnicell SureMed solution provides innovative medication adherence packaging to help reduce costly hospital readmissions. In addition, these solutions enable approximately 7,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.
Mountain View, US
Size (employees)
2,444 (est)
Omnicell was founded in 1992 and is headquartered in Mountain View, US

Omnicell Office Locations

Omnicell has office in Mountain View
Mountain View, US

Omnicell Metrics

Omnicell Summary

Market capitalization

$1.5 b

Closing share price

Omnicell's current market capitalization is $1.5 b.

Omnicell Financials

Omnicell's revenue is $692.6 m in FY, 2016 which is a 42.9% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016


$380.6 m$440.9 m$484.6 m$692.6 m

Revenue growth, %


Gross profit

$203.4 m$233.9 m$247.9 m

Operating expense total

$168.1 m$184.3 m$199.3 m


$35.3 m$49.6 m$48.6 m

Net Income

$24 m$30.5 m$30.8 m$603 k

Operating cash flow

$42.2 m$21.4 m($43.7 m)

Omnicell Market Value History

Omnicell Online Presence

Omnicell Company Life

You may also be interested in